TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board — TradingView News
A famend professional in insulin pharmacology, diabetes expertise, and temperature-sensitive medicine stability joins TempraMed to strengthen scientific management Vancouver, British Columbia–(Newsfile Corp. – December 10, 2025) – TempraMed Technologies Ltd.…